Cesca Therapeutics
Rancho Cordova, US · Delaware corporation
Founders & leadership
KP
Kenneth PappaExecutive
KH
Kenneth HarrisExecutive
MS
Mitchel SivilottiExecutive
MB
Mike BruchExecutive
RC
Robin C StaceyExecutive
Board
MR
Michael RheinBoard director
CW
Craig W MooreBoard director
MR
Mahendra RaoBoard director
Reported raises · per SEC filings
Form D private placements$34.6M disclosed across 5 rounds · 2014–2023
▶$3MraisedMar 2023 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedMar 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Xiaochun XuExecutive Officer, Director
- Haihong ZhuExecutive Officer, Director
- Joseph ThomisDirector
- Russell MedfordDirector
- Vivian LiuDirector
- Jeffery CaubleExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- Sales commissions
- $300K
- Placement agents
- H.C. Wainwright & Co., LLC.
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$800KraisedFeb 2019 · 1 investors · BiotechnologyRule 506(b)
▶$800KraisedFeb 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffery CaubleExecutive Officer
- Joseph ThomisDirector
- Xiaochun XuExecutive Officer, Director
- Russell MedfordDirector
- James XuDirector
- Mark WestgateDirector
- Offering amount
- $800K
- Amount sold
- $800K
- Minimum investment
- $800K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$816.9KraisedApr 2018 · 5 investors · Other Health CareRule 506(b)
▶$816.9KraisedApr 2018 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Russell MedfordDirector
- Vivian LiuExecutive Officer, Director
- Joseph ThomisDirector
- Jeff CaubleExecutive Officer
- Mark WestgateDirector
- James XuDirector
- Xiaochun XuExecutive Officer, Director
- Offering amount
- $816.9K
- Amount sold
- $816.9K
- Sales commissions
- $96.9K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedFeb 2016 · 2 investors · Other Health CareRule 506(b)
▶$15MraisedFeb 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Craig W. MooreDirector
- Robin StraceyExecutive Officer, Director
- Michael BruchExecutive Officer
- Denis Michael RheinDirector
- Mahendra S. RaoDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedSep 2015 · 2 investors · BiotechnologyRule 506(b)
▶$15MraisedSep 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael RheinDirector
- Craig W MooreDirector
- Kenneth PappaExecutive Officer
- Mahendra RaoDirector
- Kenneth HarrisExecutive Officer, Director
- Mitchel SivilottiExecutive Officer
- Mike BruchExecutive Officer
- Robin C StaceyExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- Sales commissions
- $1.2M
- Placement agents
- Maxim Group LLC
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cesca Therapeutics raised?
- Cesca Therapeutics has disclosed $34.6M raised across 5 rounds.
- Where is Cesca Therapeutics headquartered?
- Cesca Therapeutics is headquartered in Rancho Cordova, US.